Regonat 40MG Tablet (28’s) is a prescription medication that contains Regorafenib as its active ingredient, with each tablet delivering a dosage of 40 mg. This drug is primarily used in the treatment of various types of cancer, including metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma. Regorafenib functions as a multi-kinase inhibitor, targeting several pathways involved in tumor growth and angiogenesis, thereby helping to slow down the progression of cancer. The composition of Regonat also includes inactive ingredients that aid in the tablet’s formulation, ensuring stability and efficacy. As a targeted therapy, Regonat is designed to interfere with the cancer cells’ ability to grow and spread, making it a crucial option in oncology treatment regimens. Patients prescribed Regonat should be aware of its potential side effects and the importance of adhering to their healthcare provider’s instructions for optimal results.